Patient-specific cancer tumours replicated in 3D bioprinting advance

Bowel cancer patients could in future benefit from a new 3D bioprinting technology which would use their own cells to replicate the complex cellular environment of solid tumours in 3D models. The University of Bristol-led advance, published in Biofabrication, would allow clinicians to treat the models, known as spheroids, with chemotherapy drugs and radiation to help them understand an individual patient ’ s resistance to therapies.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Health, Research; Faculty of Life Sciences, School of Cellular and Molecular Medicine, Faculty of Life Sciences; Press Release Source Type: news